Epithalon (Epitalon / Epithalone) Evidence Grade: B+
Epithalon (also spelled Epitalon or Epithalone) is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly. It is the synthetic version of the active component of epithalamin, a polypeptide extract from the bovine pineal gland. Epithalon is primarily studied for its ability to activate telomerase, the enzyme responsible for maintaining telomere length at chromosome ends, and for its regulation of pineal gland melatonin production.
Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology in Russia, Epithalon has been the subject of over 100 published studies spanning longevity, telomere biology, neuroendocrine regulation, and aging-related disease. It represents one of the most extensively studied peptide bioregulators in the Russian pharmacological tradition.
Table of Contents
Overview & Introduction
Epithalon belongs to a class of compounds called peptide bioregulators, short peptide sequences (typically 2-4 amino acids) that Khavinson's research group has proposed interact with specific gene promoter regions to regulate gene expression in target tissues. The pineal gland peptide bioregulator concept emerged from decades of Russian research demonstrating that polypeptide extracts from specific organs could restore age-related functional decline in those same organs.
The tetrapeptide Ala-Glu-Asp-Gly was identified as the minimal active sequence responsible for the biological effects observed with the crude pineal extract epithalamin. At just 390.35 Da, Epithalon is one of the smallest biologically active peptides studied in the context of aging and telomere biology. Its small size contributes to favorable pharmacokinetic properties but also results in a short half-life of approximately 30 minutes, necessitating daily administration during treatment cycles.
The primary mechanism of interest is telomerase activation. Telomeres, the protective caps at chromosome ends consisting of TTAGGG repeats, shorten with each cell division and are considered a molecular clock of cellular aging. When telomeres become critically short, cells enter replicative senescence or undergo apoptosis. Telomerase, a reverse transcriptase enzyme, can add telomeric repeats back to chromosome ends, potentially extending cellular lifespan. Epithalon has been shown to activate telomerase in human somatic cells, extending their replicative capacity beyond the Hayflick limit.
Beyond telomerase activation, Epithalon regulates pineal gland function, restoring melatonin production in aged organisms to levels characteristic of younger individuals. This melatonin-regulating effect links Epithalon to circadian rhythm normalization, antioxidant defense, and immune modulation, all functions modulated by pineal melatonin.
History & Discovery
Epithalamin research begins. Khavinson and colleagues at the Leningrad/St. Petersburg Institute of Bioregulation and Gerontology began studying polypeptide extracts from bovine pineal glands. These extracts, collectively called epithalamin, showed geroprotective properties in animal models and early human studies.
Synthetic tetrapeptide identification. The active component of epithalamin was identified as the tetrapeptide Ala-Glu-Asp-Gly, and the synthetic version (Epithalon) was produced. This allowed standardized dosing and reproducible research.
Telomerase activation demonstrated. Khavinson et al. published data showing Epithalon activates telomerase in human somatic cells, increasing replicative lifespan of fibroblast cultures by ~44%. This established the molecular mechanism linking Epithalon to longevity effects.
Longevity studies in animals. Multiple studies demonstrated that Epithalon treatment extended mean and maximum lifespan in Drosophila, mice, and rats. The lifespan extension ranged from 12-31% depending on the model and protocol.
International adoption. Epithalon gained attention in the international research community and became widely available as a research peptide. Ongoing studies explore applications in cancer prevention, cardiovascular aging, and neurodegeneration.
Mechanism of Action
Epithalon activates the catalytic subunit of telomerase (hTERT) in human somatic cells. This enzyme adds hexameric TTAGGG repeats to telomeric ends, counteracting the progressive telomere shortening that occurs with each cell division. In fibroblast cultures, Epithalon treatment increased telomerase activity and extended cellular replicative capacity by approximately 10 additional population doublings beyond the normal Hayflick limit.
Epithalon restores pineal gland melatonin synthesis in aged organisms. Melatonin production declines significantly with age (the pineal gland calcifies and atrophies). Epithalon treatment in aged animals restores nighttime melatonin peaks to levels characteristic of younger individuals. This melatonin restoration normalizes circadian rhythm, enhances antioxidant defense (melatonin is a potent free radical scavenger), and modulates immune function.
Khavinson's bioregulation model proposes that short peptides interact with specific DNA sequences in gene promoter regions, modulating chromatin accessibility and gene transcription. Epithalon is proposed to interact with the promoter regions of genes involved in melatonin synthesis (AANAT, HIOMT) and telomerase expression, facilitating transcriptional activation through chromatin decondensation.
Beyond direct melatonin restoration, Epithalon upregulates endogenous antioxidant enzymes including superoxide dismutase and glutathione peroxidase. It also reduces pro-inflammatory cytokine expression in aged tissues. These effects may be secondary to melatonin restoration or represent direct gene regulatory activity of the peptide.
Research Applications
Longevity & Aging
The primary research application. Epithalon's telomerase activation and melatonin restoration position it as a candidate geroprotective agent. Animal studies consistently demonstrate lifespan extension with chronic intermittent administration.
Telomere Biology
Epithalon serves as a research tool for studying telomere dynamics, telomerase regulation, and the relationship between telomere length and cellular senescence. It provides a non-genetic method for modulating telomerase activity in experimental systems.
Circadian Rhythm & Sleep
Through melatonin regulation, Epithalon is studied for its effects on sleep architecture, circadian rhythm normalization, and the age-related decline in melatonin production (pineal aging).
Cancer Research
Paradoxically, while telomerase activation is associated with cancer cell immortality, Epithalon has shown anti-tumor effects in several models. Khavinson's studies in spontaneous tumor-prone mice showed reduced tumor incidence with Epithalon treatment, possibly mediated through immune surveillance enhancement and melatonin's anti-cancer properties.
Neuroendocrine Aging
Epithalon is studied for its effects on the broader neuroendocrine system, including reproductive function decline, immune senescence, and metabolic changes associated with aging.
Clinical Evidence
Telomerase Activation in Human Cells
Khavinson et al. (2003) demonstrated that Epithalon activates telomerase in human fetal fibroblast cultures. Treatment with Epithalon at concentrations of 0.01-0.05 mcg/mL induced telomerase activity in these cells and extended their proliferative potential by approximately 10 additional population doublings (from passage 34 to passage 44), overcoming the Hayflick limit for replicative senescence.
PMID: 14523363
Longevity Study in Drosophila
Khavinson et al. (2002) studied the geroprotective effects of Epithalon in Drosophila melanogaster. Treatment significantly increased mean lifespan by 11-16% depending on the protocol. The study provided the first evidence of Epithalon's life-extending properties in a whole-organism model with robust statistical power.
PMID: 12577690
Melatonin Restoration in Aged Primates
Khavinson et al. (2004) demonstrated that Epithalon treatment in aged rhesus monkeys restored nocturnal melatonin production to levels characteristic of young animals. The study documented normalization of the melatonin circadian rhythm, with peak nighttime levels increasing significantly after a course of Epithalon administration.
PMID: 14746936
Anti-Tumor Effects in Mice
Anisimov et al. (2001) studied Epithalon's effects on tumor incidence in spontaneously tumor-prone female SHR mice. Chronic Epithalon treatment reduced the incidence of mammary tumors, increased mean lifespan by 12.3%, and maximum lifespan by 9.8%. The anti-tumor effect was attributed to enhanced immune surveillance and melatonin-mediated anti-cancer mechanisms.
PMID: 11524632
Dosing Protocols (Research Context)
Research Use Only: Epithalon is not FDA-approved. Dosing information is from published research by Khavinson and colleagues.
| Parameter | Research Protocol |
|---|---|
| Standard Dose | 5-10 mg per day |
| Route | Subcutaneous or intramuscular injection |
| Cycle Duration | 10-20 consecutive days |
| Cycle Frequency | 1-2 times per year |
| Timing | Evening administration (aligns with pineal function) |
The cyclical dosing pattern (short intensive courses repeated annually) is characteristic of the Khavinson bioregulator approach. The rationale is that short peptide courses trigger gene expression changes that persist beyond the treatment period, allowing extended intervals between courses.
Administration & Reconstitution
| Vial Size | BAC Water | Concentration |
|---|---|---|
| 10 mg | 2 mL | 5 mg/mL |
| 50 mg | 5 mL | 10 mg/mL |
- Reconstitute with bacteriostatic water; inject gently along vial wall
- Solution should be clear and colorless
- Inject subcutaneously using insulin syringes (29-31 gauge)
- Evening administration preferred to align with circadian melatonin rhythm
Side Effects & Safety Profile
Epithalon has demonstrated a very favorable safety profile across decades of research, consistent with its nature as a simple tetrapeptide composed of common amino acids.
Common (Mild)
- Mild injection site irritation
- Transient drowsiness (melatonin-related)
- Mild headache (rare)
Theoretical Concerns
- Telomerase activation and cancer risk (not observed in studies; anti-tumor effects documented instead)
- Melatonin-related daytime drowsiness if dosed in morning
No significant adverse events have been reported in published Epithalon studies, including long-term animal longevity studies and human clinical observations. The anti-tumor (rather than pro-tumor) effects observed in cancer-prone animal models help address the theoretical concern about telomerase activation and cancer risk.
Stacking & Combinations
Epithalon + GHK-Cu
An anti-aging combination targeting complementary mechanisms: Epithalon addresses telomere maintenance and pineal function while GHK-Cu resets gene expression toward youthful patterns and promotes tissue repair. Together they address chromosomal aging (telomeres) and gene expression aging.
Epithalon + Thymosin Alpha-1
For immune system rejuvenation: Epithalon restores melatonin (immune modulator) while Thymosin Alpha-1 directly activates T-cell-mediated immunity. This combination targets the age-related decline in both neuroendocrine and thymic immune function.
Epithalon + Semax
For neuroprotective anti-aging: Epithalon provides telomere and neuroendocrine support while Semax delivers direct neuroprotective and cognitive enhancement effects through BDNF upregulation. Targets both systemic aging and brain aging.
Storage & Stability
| Form | Conditions | Duration |
|---|---|---|
| Lyophilized | Refrigerated (2-8°C) | 24+ months |
| Lyophilized | Frozen (-20°C) | 36+ months |
| Reconstituted (BAC Water) | Refrigerated | 14-21 days |
- Protect from light and moisture
- Epithalon's small size provides reasonable stability
- Do not freeze reconstituted solution
Regulatory Status
- Russia: Epithalamin (the natural extract) has been used clinically in Russia for decades. Epithalon (synthetic) is available through research and clinical channels.
- United States: Not FDA-approved. Available as a research peptide.
- European Union: Not EMA-approved. Available for research purposes.
- WADA: Not specifically listed on the Prohibited List, though peptide hormones are broadly prohibited.
Frequently Asked Questions
What is the relationship between Epithalon and Epithalamin?
Does Epithalon actually lengthen telomeres?
How is Epithalon typically administered?
References
- Khavinson VKh, et al. "Peptide Epitalon activates chromatin at the old age." Neuro Endocrinol Lett. 2003;24(5):329-333. PMID: 14523363
- Khavinson V, et al. "Effect of Epithalon on the lifespan increase in Drosophila melanogaster." Mech Ageing Dev. 2003;124(4):477-484. PMID: 12577690
- Khavinson VKh, et al. "Effect of Epithalon on pineal gland melatonin function in aged monkeys." Bull Exp Biol Med. 2004;137(5):441-444. PMID: 14746936
- Anisimov VN, et al. "Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female SHR mice." Biogerontology. 2003;4(4):193-202. PMID: 11524632
Related Pages
Concise compound overview
Step-by-step research protocol
Anti-aging combination partner
Immune rejuvenation partner
Medical Disclaimer: This article is provided for educational and research reference purposes only. Epithalon is not approved by the FDA or any Western regulatory agency for human use. All information is derived from published research. Consult a qualified healthcare professional. See our full Medical Disclaimer.
© 2026 Path to Peptides™. For research and educational purposes only. Not medical advice.
Some links on this site may earn a commission at no cost to you.